Training in Cardiovascular Translational Research
Training in Cardiovascular Translational Research
批准号:
10546477
负责人:
ANDREW Robert MARKS
金额:
$44.17万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2024-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
This application requests continued funding for a pre-doctoral (6 slots, an increase of 2 slots) and post-
doctoral (4 slots, remains the same) training grant entitled, `Training in Cardiovascular Translational
Research'. The goal is to train future CV scientists who have expertise in bringing basic discoveries from the
laboratory into clinical practice through development of novel therapeutics. The KEY INNOVATION is a
course covering the major disciplines required for successful therapeutics discovery, validation and
development including: 1) basic mechanisms in CV diseases/target identification; 2) drugging the target/high
throughput screening; 3) target validation/proof of concept using relevant animal models of human disease;
4) introduction to medicinal chemistry – optimization of compounds/biologicals; 5) basic concepts of
intellectual property protection; 6) fundamentals of medical pharmacology; 6) basics in toxicology; 7)
principals of drug development from pre-clinical to IND filing; 8) fundamentals of clinical testing. A new
dimension to this highly successful program focuses on structure-based cardiovascular drug discovery.
Faculty mentors direct research training in four primary areas: 1) Structural Biology of CV Signaling
Molecules, including solving structures of ion channels and G-protein coupled receptors; 2) Biophysics of CV
Cell Signaling, including ion channels, cardiac and smooth muscle signaling; 3) Animal Models of CV
Diseases, including mice models of heart failure, cardiac arrhythmias, atherosclerosis, and diabetes; and 4)
Clinical-Translational CV Sciences, including integrated use of human stem cells, genetics of cardiovascular
diseases, biomaterial scaffolds and bioreactors, clinical electrophysiology, and heart failure. Another
innovation provides clinical exposure/training for pre- and postdoctoral trainees who are introduced to clinical
activities in the hospital under the supervision of cardiology fellows in order to gain appreciation of the
relevance of their basic research to human CV disease. Trainees apply for independent funding to continue
their training after two years of grant support. Pre-doctoral candidates are selected from a large and diverse
pool of outstanding applicants to 7 graduate programs at Columbia University Medical Center─ Cellular
Physiology and Biophysics, Biochemistry and Molecular Biophysics, Pathology and Cell Biology, the
Integrated Program, Nutritional and Metabolic Biology, Pharmacology and Molecular Signaling. Post-doctoral
candidates are selected from a large applicant pool of direct applicants to program faculty. Ongoing efforts
to recruit of woman and minorities continue to be successful. The training program provides cardiovascular
seminar series, journal clubs, joint laboratory meetings and retreats that foster collaborations and
interdisciplinary research. The program takes advantage of the many existing strengths of Columbia
University, including the Irving Center for Clinical and Translational Research (CTSA), Mailman School of
Public Health, Genome Center, Bioinformatics, and Tissue and Biomedical Engineering.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Engineering selectivity into RGK GTPase inhibition of voltage-dependent calcium channels.
对电压依赖性钙通道的 RGK GTPase 抑制进行工程选择性。
DOI:
10.1073/pnas.1811024115
发表时间:
2018
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Puckerin,AkilA, Chang,DonaldD, Shuja,Zunaira, Choudhury,Papiya, Scholz,Joachim, Colecraft,HenryM]
通讯作者:
Colecraft,HenryM
Normal Hematopoiesis Is a Balancing Act of Self-Renewal and Regeneration.
正常造血是自我更新和再生的平衡行为。
DOI:
10.1101/cshperspect.a035519
发表时间:
2020
期刊:
Cold Spring Harbor perspectives in medicine
影响因子:
5.4
作者:
[Olson,OakleyC, Kang,Yoon-A, Passegué,Emmanuelle]
通讯作者:
Passegué,Emmanuelle
Insulin sensitization by hepatic FoxO deletion is insufficient to lower atherosclerosis in mice.
肝 FoxO 缺失引起的胰岛素敏化不足以降低小鼠的动脉粥样硬化。
DOI:
10.1101/2023.10.14.562366
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Izquierdo,MaríaConcepción, Harris,Michael, Shanmugarajah,Niroshan, Zhong,Kendra, Ozcan,Lale, Fredman,Gabrielle, Haeusler,RebeccaA]
通讯作者:
Haeusler,RebeccaA
DOI:
10.1093/pnasnexus/pgad336
发表时间:
2023-11
期刊:
PNAS NEXUS
影响因子:
--
作者:
[Dridi, Haikel, Yehya, Marc, Barsotti, Robert, Liu, Yang, Reiken, Steven, Azria, Lan, Yuan, Qi, Bahlouli, Laith, Soni, Rajesh Kumar, Marks, Andrew R., Lacampagne, Alain, Matecki, Stefan]
通讯作者:
Matecki, Stefan
DOI:
10.1038/s41598-022-13128-x
发表时间:
2022-06-09
期刊:
SCIENTIFIC REPORTS
影响因子:
4.6
作者:
[Delventhal, Rebecca, Wooder, Emily R., Basturk, Maylis, Sattar, Mohima, Lai, Jonathan, Bolton, Danielle, Muthukumar, Gayathri, Ulgherait, Matthew, Shirasu-Hiza, Mimi M.]
通讯作者:
Shirasu-Hiza, Mimi M.
共 12 条
Ryanodine receptor structure and function in heart failure
-
批准号:10628917
-
项目类别:
-
资助金额:$42.77万
-
财政年份:2023
-
负责人:ANDREW Robert MARKS
-
依托单位:
Summer Program for Under Represented Students (SPURS)
-
批准号:10583050
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2022
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Sciences for Under Represented Students
-
批准号:10669557
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2021
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Sciences for Under Represented Students
-
批准号:10115469
-
项目类别:
-
资助金额:$12.4万
-
财政年份:2021
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Sciences for Under Represented Students
-
批准号:10397516
-
项目类别:
-
资助金额:$12.4万
-
财政年份:2021
-
负责人:ANDREW Robert MARKS
-
依托单位:
Calcium and the Pathophysiology of Neurodegenerative Disorders
-
批准号:10052965
-
项目类别:
-
资助金额:$231.02万
-
财政年份:2020
-
负责人:ANDREW Robert MARKS
-
依托单位:
Calcium and the physiology of diabetes
-
批准号:10357858
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants
-
批准号:10407960
-
项目类别:
-
资助金额:$76.28万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations
-
批准号:9904328
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Calcium and the physiology of diabetes
-
批准号:9923637
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations
-
批准号:10376824
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2019
-
负责人:ANDREW Robert MARKS
-
依托单位:
Exploring the Molecular Physiology of Atrial Fibrillation
-
批准号:10544556
-
项目类别:
-
资助金额:$77.23万
-
财政年份:2018
-
负责人:ANDREW Robert MARKS
-
依托单位:
Exploring the Molecular Physiology of Atrial Fibrillation
-
批准号:10366410
-
项目类别:
-
资助金额:$76.76万
-
财政年份:2018
-
负责人:ANDREW Robert MARKS
-
依托单位:
Exploring the Molecular Physiology of Atrial Fibrillation
-
批准号:10063900
-
项目类别:
-
资助金额:$71.81万
-
财政年份:2018
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Translational Research
-
批准号:8608392
-
项目类别:
-
资助金额:$21.35万
-
财政年份:2014
-
负责人:ANDREW Robert MARKS
-
依托单位:
Training in Cardiovascular Translational Research
-
批准号:10408665
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2014
-
负责人:ANDREW Robert MARKS
-
依托单位:
Administrative Core
-
批准号:8236898
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci
-
批准号:8106862
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci
-
批准号:8301586
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci
-
批准号:8656743
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2011
-
负责人:ANDREW Robert MARKS
-
依托单位:
海外基金